# Aura Biosciences, Inc.: Form 8-K, filed Apr 2, 2025

- Company: [Aura Biosciences, Inc.](/companies/aura.md) (CIK 1501796)
- Form: 8-K
- Filed: 2025-04-02
- Accepted by EDGAR: Apr 2, 2025, 07:15 ET
- Period: 2025-03-31
- Accession: 0000950170-25-048880
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1501796/000095017025048880/aura-20250331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501796/000095017025048880/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501796/000095017025048880/aura-20250331.htm

Filed Apr 2, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-048880. Last ingested by Listed: Oct 27, 2026, 17:26 ET. No prices; not investment advice.